PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-22 (4)

Date Title Company
22-Apr-2026 Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS Businesswire